Sherry Y. Wu

9.4k total citations · 1 hit paper
66 papers, 4.4k citations indexed

About

Sherry Y. Wu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Sherry Y. Wu has authored 66 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 22 papers in Cancer Research and 10 papers in Immunology. Recurrent topics in Sherry Y. Wu's work include RNA Interference and Gene Delivery (15 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (9 papers). Sherry Y. Wu is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (9 papers). Sherry Y. Wu collaborates with scholars based in United States, Australia and China. Sherry Y. Wu's co-authors include Anil K. Sood, Susan Hua, Fatemeh Moheimani, Gabriel Lopez‐Berestein, Nigel A.J. McMillan, George A. Călin, Cristina Ivan, Keith Baggerly, Rajesha Rupaimoole and Cristian Rodriguez‐Aguayo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biomaterials.

In The Last Decade

Sherry Y. Wu

62 papers receiving 4.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances and Challenges of Liposome Assisted Drug Delivery

2015 1.9k citations Sherry Y. Wu, Anil K. Sood et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sherry Y. Wu	2.6k	1.1k	829	725	537	66	4.4k
Marcel H.A.M. Fens	1.7k 0.7×	1.0k 0.9×	720 0.9×	583 0.8×	406 0.8×	69	3.3k
Xinli Liu	2.3k 0.9×	528 0.5×	949 1.1×	385 0.5×	370 0.7×	169	4.3k
Huan Wang	1.7k 0.7×	753 0.7×	912 1.1×	385 0.5×	607 1.1×	208	4.4k
Xun Sun	1.4k 0.5×	691 0.6×	1.0k 1.2×	360 0.5×	543 1.0×	60	2.9k
Song Li	2.7k 1.0×	1.2k 1.1×	1.1k 1.4×	577 0.8×	1.1k 2.0×	171	5.8k
Joy Wolfram	3.4k 1.3×	1.5k 1.4×	1.6k 2.0×	1.3k 1.7×	537 1.0×	96	5.8k
M. Guillaume Wientjes	2.6k 1.0×	1.5k 1.3×	1.2k 1.4×	644 0.9×	327 0.6×	129	6.2k
Olga B. Garbuzenko	2.5k 1.0×	1.7k 1.5×	1.1k 1.3×	356 0.5×	296 0.6×	49	4.6k
Christopher M. Jewell	3.0k 1.2×	654 0.6×	1.2k 1.4×	1.2k 1.6×	1.9k 3.6×	133	6.3k
Jayesh A. Kulkarni	5.8k 2.2×	1.0k 0.9×	1.1k 1.3×	490 0.7×	995 1.9×	47	7.2k

Countries citing papers authored by Sherry Y. Wu

Since Specialization

Citations

This map shows the geographic impact of Sherry Y. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Y. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Y. Wu more than expected).

Fields of papers citing papers by Sherry Y. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry Y. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Y. Wu. The network helps show where Sherry Y. Wu may publish in the future.

Co-authorship network of co-authors of Sherry Y. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Y. Wu. A scholar is included among the top collaborators of Sherry Y. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Y. Wu. Sherry Y. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Qian, Sherry Y. Wu, Qiong Gao, et al.. (2025). Visualizing orbital-level d-band modulation in RuCoN nanoalloys anchored on N-doped carbon nanotubes for efficient alkaline AEM water electrolysis. Nano Research. 19(3). 94908263–94908263.

Gong, Ying, Ruyi Zhang, Haoran Wu, et al.. (2025). Advances in Cellular Immune Theranostic Approaches for Glioblastoma: Current Trends and Future Directions. PubMed. 4(4). e70018–e70018. 1 indexed citations

Chen, Suming, Chintan Bhavsar, Rohan Lourie, Shuying Li, & Sherry Y. Wu. (2025). Development of an innovative extracellular vesicle mimetic delivery platform for efficient miRNA delivery to tumours. Biomaterials. 321. 123282–123282. 2 indexed citations

Liao, Xiao-Hui, Sherry Y. Wu, Yufen Li, et al.. (2025). Methylation-Mediated Silencing of miR-124-3 Regulates LRRC1 Expression and Promotes Oral Cancer Progression. Cancers. 17(7). 1136–1136. 1 indexed citations

Wilkinson, A, Rui Chen, Chintan Bhavsar, et al.. (2024). Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth. Cancer Immunology Immunotherapy. 73(5). 80–80. 6 indexed citations

Alharbi, Mona, Andrew Lai, Dominic Guanzon, et al.. (2024). Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering. International Journal of Cancer. 155(8). 1510–1523. 5 indexed citations

McGuire, Michael H., Santosh K. Dasari, Hui Yao, et al.. (2021). Gene Body Methylation of the Lymphocyte-Specific Gene CARD11 Results in Its Overexpression and Regulates Cancer mTOR Signaling. Molecular Cancer Research. 19(11). 1917–1928. 6 indexed citations

Miyake, Takahito, Sunila Pradeep, Emine Bayraktar, et al.. (2020). NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors. Molecular Cancer Therapeutics. 19(8). 1727–1735. 8 indexed citations

Noh, Kyunghee, Duc‐Hiep Bach, Hyun Jin Choi, et al.. (2020). The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis. Oncogene. 40(2). 384–395. 19 indexed citations

10.

Ma, Shaolin, Sunila Pradeep, Alejandro Villar‐Prados, et al.. (2019). GnRH-R–Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition. Molecular Cancer Therapeutics. 18(5). 969–979. 13 indexed citations

11.

Shi, Sixiang, Tingting Li, Xiaofei Wen, et al.. (2019). Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention. Bioconjugate Chemistry. 30(10). 2675–2683. 83 indexed citations

12.

Villar‐Prados, Alejandro, Sherry Y. Wu, Karem A. Court, et al.. (2018). Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4. Molecular Cancer Therapeutics. 18(2). 421–436. 10 indexed citations

13.

Wu, Sherry Y., Arthi Thirumalai, Ronald S. Swerdloff, et al.. (2018). Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel. Andrology. 7(2). 235–243. 14 indexed citations

14.

Wu, Sherry Y., Ronald S. Swerdloff, Youngju Pak, et al.. (2018). Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11 β -Methyl-19-Nortestosterone-17 β -Dodecylcarbonate in Men. The Journal of Clinical Endocrinology & Metabolism. 104(3). 629–638. 34 indexed citations

15.

Wagner, Michael J., Rahul Mitra, Mark J. McArthur, et al.. (2017). Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA). Molecular Cancer Therapeutics. 16(6). 1114–1123. 101 indexed citations

16.

Court, Karem A., Hiroto Hatakeyama, Sherry Y. Wu, et al.. (2017). HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer. Molecular Cancer Therapeutics. 16(5). 966–976. 45 indexed citations

17.

Yokoyama, Yuhki, Hengrui Zhu, Jeong Heon Lee, et al.. (2016). BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer. Cancer Research. 76(21). 6320–6330. 116 indexed citations

18.

McDonnell, Erin, Min Wu, Sherry Y. Wu, et al.. (2015). mycoCLAP, the database for characterized lignocellulose-active proteins of fungal origin: resource and text mining curation support. Database. 2015. 18 indexed citations

19.

Tucker, Susan L., Kshipra M. Gharpure, Shelley M. Herbrich, et al.. (2014). Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 20(12). 3280–3288. 68 indexed citations

20.

Gharpure, Kshipra M., Kevin S. Chu, Charles J. Bowerman, et al.. (2014). Metronomic Docetaxel in PRINT Nanoparticles and EZH2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer. Molecular Cancer Therapeutics. 13(7). 1750–1757. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact